(IN KÜRZE) Das BioSense Institute in Novi Sad hat ein neues Gebäude eröffnet, das moderne Einrichtungen für wissenschaftliche Forschung und Geschäftsvorhaben in den Bereichen Landwirtschaft und Biotechnologie bietet. Das 34-Millionen-Euro-Projekt wurde mit 14 Millionen Euro an EU-Zuschüssen, 20 Millionen Euro … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged Ana Brnabić, ANTARES-Projekt, BioSense Institute, biotechnologie, Biowissenschaften, Branko Ružić, EIB, Europäische Investitionsbank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, Jugend Mariya Gabriel, Landwirtschaft, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, Serbien, start-ups, Tanja Miščević, Universität Novi Sad, Vladimir Crnojević, wissenschaftliche Forschung
(IN BRIEF) The BioSense Institute in Novi Sad has opened a new building offering modern facilities for scientific research and business ventures in the fields of agriculture and biotechnology. The €34 million project was financed by €14 million in EU … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged agriculture, Ana Brnabić, ANTARES project, BioSense Institute, biotechnology, Branko Ružić, EIB, European Investment Bank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, life sciences, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, scientific research, SERBIA, Startups, Tanja Miščević, University of Novi Sad, Vladimir Crnojević, Youth Mariya Gabriel
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
